PD0325901 is the selective inhibitor of mitogen activated protein kinase kinase (MEK or MAPKK) with IC50 about 1nM against activated MEK1 and MEK2. Its potency, solubility and effectiveness are all much better than CI-1040. Anticancer activity of PD0325901 has been demonstrated for a broad spectrum of human tumor xenografts. When using with GSK-3β inhibitor CHIR99021, PD0325901 could prevent cell differentiation and sustain ES cell self-renewal.
Technical information:
Chemical Formula: | C16H14F3IN2O4 | |
CAS #: | 391210-10-9 | |
Molecular Weight: | 482.19 | |
Purity: | >98% | |
Appearance: | Off white solid | |
Chemical Name: | N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide | |
Solubility: | Up to 50 mM in DMSO |
Shipping Condition: The product is shipped in a glass vial at ambient temperature.Storage: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.
Reference:
1. | Barrett, S.D., et al. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg. Med. Chem. Lett. (2008), 18: 6501-6504. |
2. | Judith S. Sebolt-Leopold et al. The biological profile of PD 0325901: A second generation analog of CI-1040 with improved pharmaceutical potential . Proc Amer Assoc Cancer Res, Volume 45, 2004. |
3. | Tongxiang Lin, et al. A chemical platform for improved induction of human iPSCs. Nature Methods 6, 805 - 808 (2009) |
Other Information:
Product Specification (pdf)MSDS (pdf)
Cellagen利用广泛的研究以及我们在干细胞生物学,药物化学和产品开发方面的专业知识,Cellagen长期以来一直为专业OEM产品提供世界领先的公司,为一线干细胞研究奠定了基础。
现在,Cellagen扩展了其最佳产品系列,并直接向研究界提供。Cellagen与世界领先的科学家有着密切的联系,并且始终认识到高标准科学研究的未满足需求。